Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity ...Middle East

ROCKVILLE, Md. and SUZHOU, China, Jan. 1, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity )

Also on site :

• Former student kills 10 people in Austrian high school shooting
• Chart-Topping '90s Rocker, 59, Stuns Fans With Unexpected Side Career
• Country Legend Makes Generous Donations Across North America This Summer